Turn Therapeutics Inc.
TTRX
$3.98
$0.102.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.19M | -3.80M | -2.56M | -2.16M | -1.77M |
| Total Depreciation and Amortization | 52.90K | 51.10K | 49.50K | 48.50K | 47.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.79M | 462.30K | 671.50K | 516.50K | 361.50K |
| Change in Net Operating Assets | 2.37M | 1.47M | 232.70K | 115.40K | -1.90K |
| Cash from Operations | -2.56M | -1.82M | -1.60M | -1.48M | -1.36M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -153.00K | -129.40K | -83.10K | -91.30K | -99.50K |
| Cash from Investing | -153.00K | -129.40K | -83.10K | -91.30K | -99.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.92M | 4.26M | 3.99M | 2.57M | 1.15M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.92M | 4.26M | 3.99M | 2.57M | 1.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.20M | 2.32M | 2.31M | 998.30K | -308.40K |